5 Stocks Trading With Incredibly Low Price-to-Book Values
In a momentum stock market, investors rarely look at anything other than the stock price, but when the market gets rich, and shares start to get shaky like we are seeing now, they often…
In a momentum stock market, investors rarely look at anything other than the stock price, but when the market gets rich, and shares start to get shaky like we are seeing now, they often…
The cybersecurity stocks that have taken a beating this summer have been reporting big numbers this week, and investors are re-entering the stocks at a furious pace.
A new report from Cowen notes that the giant carriers' light first-half spending combined with unchanged total 2015 guidance could be big for the Verizon's communications equipment suppliers.
If there was ever a measure of internal corporate bullishness, especially when a company is generating substantial free cash flow, it is how much stock the company is buying back in the open market.
A new report from RBC says to take advantage of selling in three top tech stocks now, for what could be solid gains not far down the road.
Some investors may raise an eye as Merrill Lynch adds Facebook at prices near a 52-week high. The bottom line is the company is basically in a world with no competition.
This is the perfect time for aggressive growth investors to look to value stocks for a rotation, and a new report from Jefferies highlights five top picks for this week.
A new report from Cowen says that in the next two years the U.S. natural gas market could turn from a domestic to an international market.
Price to cash flow can be a very good indicator on when a stock is truly cheap. Here are five stocks that recently hit Merrill Lynch's screen.
Some analysts we cover on Wall Street are becoming more bullish on the utility sector after it took a big hit this year.
For years the fabless chip makers seemed to have the upper hand as they designed their own semiconductors, but outsourced the actual manufacturing to others.
The Jefferies focus picks may seem like momentum stocks, but they truly have outstanding underlying fundamentals, and despite a few having tremendous moves lately, the Jefferies team sees plenty of upside.
With the chances for a perhaps serious market correction mounting, now may be a great time for stock investors to start rotating out of momentum into solid growth stocks.
A new research report from Cowen focuses on the top biotech stocks to buy before second-quarter earnings are reported.
One would think that a sizable rally after weeks of up and down trading would bring insider sellers out of the woodwork, but that certainly wasn’t the case this past week.
The double whammy of slower summer trading and second-quarter earnings hitting the tape daily usually can act as a roadblock for insider buying,
A new UBS report notes that the top communications equipment stocks in the firm's universe have pulled back over the past two weeks over various macro concerns and may be offering investors a very…
The analysts at Cowen have calculated the buys and sells in the NYSE Arca Biotechnology Index based on the holdings in the First Trust Biotechnology ETF.
The Merrill Lynch team cite high-dividend growth as the firm's preferred exposure in a rising interest rate scenario. These stocks outperformed in the second quarter.
With the data crunched, Cowen analysts are very positive on three top software stocks to buy before the second-quarter earnings print.